B

Belite Bio
D

BLTE

155.250
USD
0.28
(0.18%)
مفتوح الان
حجم التداول
934
الربح لكل سهم
1
العائد الربحي
-
P/E
-81
حجم السوق
5,824,146,308
المقالات

العنوان: Belite Bio

القطاع: Healthcare
الصناعة: Biotechnology
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.